Title

Summary

Boston embarks on two significant clinical trials

According to researchers, a significant percentage of coronary artery disease (almost 30%) occur...[more]

Biotronik announces the 1000th enrollment in the TRUST Clinical Study

The 1000th patient has been enrolled in Biotronik's TRUST Study (Lumos-T Safely RedUceS RouTine ...[more]

World's first clinical trial designed to study DES treatment in women

The first patient has been enrolled in Abbott's XIENCE V SPIRIT WOMEN clinical trial, which is t...[more]

Appraisal completes patient enrollment

Cook Medical has completed target patient enrollment and six-month follow-up data in phase II of...[more]

Study examines effectiveness of NeuroFlo technology in stroke patients following thrombolysis

The first patient has been treated with NeuroFlo perfusion augmentation technology (developed by...[more]

First implant of Trifecta Stented Tissue Heart Valve

An estimated 170,000 patients worldwide undergo aortic tissue heart valve replacements annually,...[more]

Nuvelo to resume alfimeprase programmes

Nuvelo will resume development of alfimeprase, its lead investigational product candidate for th...[more]

PEPCAD III assesses coated balloon catheter with premounted uncoated stent

In a joint research project with Professor Ulrich Speck of the Berlin Charité, Germany, Dr Bruno...[more]

Acorn Cardiovascular …Changing lives

Acorn Cardiovascular, a privately held medical device company located in St Paul, MN, was incorp...[more]

ev3 and FoxHollow announce merger plans

ev3 Inc. and FoxHollow Technologies have announced a definitive agreement to merge in a deal wor...[more]

Merck boosts clinical pipeline of cardiovascular drug candidates

Merck Inc., and NovaCardia, Inc., have entered into a definitive agreement under which Merck wil...[more]

The Medicines Company reacquires Angiox (Bivalirudin) rights in Europe from Nycomed

The Medicines Company announced that it has reacquired all development, commercial and distribut...[more]

St Jude Medical receives FDA clearance and CE mark for devices

St Jude Medical, Inc. has recently received FDA clearance and a Health Canada License for the AC...[more]

Micrus to acquire revascularisation ischaemic stroke technology

Micrus Endovascular has signed a letter of intent to acquire the rights to a revascularisation t...[more]

Volcano Corporation announces Japan approval of the s5i Integrated IVUS Platform

Volcano Corporation has announced approval of the s5i Integrated IVUS System by necessary regula...[more]

Vascular Solutions launches Guardian Hemostasis Valve

Vascular Solutions, Inc. has announced the US launch of the Guardian haemostasis valve. Unlike c...[more]

FDA approves Ostial Pro stent positioning system

The FDA has given approval for a Kalamazoo, MI-based company to begin marketing a one-of-a-kind ...[more]

Boston Scientific receives CE mark for Taxus Liberte long stent

Boston Scientific Corporation announced that it has received CE mark for its Taxus Liberte Long ...[more]

Ablation Frontiers launches Cardiac Ablation System in Europe

Ablation Frontiers, Inc., has announced that in December 2006, it received the CE mark for its C...[more]

Abiomed announces Australian regulatory approval of Impella Circulatory Support Technologies

Abiomed, Inc, announced regulatory approval in Australia for three of its Impella products. The ...[more]